Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Cooper

Showing results (181-190 of 268) with videos related to

Pageof 27
Sort By:
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 24, 2025
Post-arrival HIV acquisition patterns: Insights from African, Caribbean, and Black immigrant communities in CanadaWangari Tharao, Thabani Nyoni, Amrita Daftary, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIVSharon L Walmsley, Leif Erik Lovblom, Bryan Boyachuk, et al.
Hepatology (Baltimore, Md.)|January 30, 2013
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patientsPaul J Pockros, Donald Jensen, Naoky Tsai, et al.
International Journal of Epidemiology|February 17, 2010
Cohort profile: the Canadian Observational Cohort collaborationAlexis K Palmer, Marina B Klein, Janet Raboud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?Sahar Saeed, Erin C Strumpf, Sharon L Walmsley, et al.
AIDS Care|December 29, 2016
Social determinants of health and retention in HIV care in a clinical cohort in Ontario, CanadaBeth Rachlis, Ann N Burchell, Sandra Gardner, et al.
Journal of the International AIDS Society|November 9, 2017
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in CanadaSahar Saeed, Erin C Strumpf, Erica Em Moodie, et al.
Infectious Diseases and Therapy|April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated AnalysisCurtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011Ann N Burchell, Sandra Gardner, Lucia Light, et al.
BMC Medical Research Methodology|August 12, 2022
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learningGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
Pageof 27

Showing results (181-190 of 268) with videos related to

Sort By:
Pageof 27
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 24, 2025
Post-arrival HIV acquisition patterns: Insights from African, Caribbean, and Black immigrant communities in CanadaWangari Tharao, Thabani Nyoni, Amrita Daftary, et al.
Antibodies (Basel, Switzerland)|April 27, 2026
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIVSharon L Walmsley, Leif Erik Lovblom, Bryan Boyachuk, et al.
Hepatology (Baltimore, Md.)|January 30, 2013
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patientsPaul J Pockros, Donald Jensen, Naoky Tsai, et al.
International Journal of Epidemiology|February 17, 2010
Cohort profile: the Canadian Observational Cohort collaborationAlexis K Palmer, Marina B Klein, Janet Raboud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?Sahar Saeed, Erin C Strumpf, Sharon L Walmsley, et al.
AIDS Care|December 29, 2016
Social determinants of health and retention in HIV care in a clinical cohort in Ontario, CanadaBeth Rachlis, Ann N Burchell, Sandra Gardner, et al.
Journal of the International AIDS Society|November 9, 2017
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in CanadaSahar Saeed, Erin C Strumpf, Erica Em Moodie, et al.
Infectious Diseases and Therapy|April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated AnalysisCurtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 1, 2015
Implementation and Operational Research: Engagement in HIV Care Among Persons Enrolled in a Clinical HIV Cohort in Ontario, Canada, 2001-2011Ann N Burchell, Sandra Gardner, Lucia Light, et al.
BMC Medical Research Methodology|August 12, 2022
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learningGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
Pageof 27